- Home
- GGR vs INMB Comparison
GGR vs INMB Comparison
Compare GGR & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GGR
- INMB
- Stock Information
- Founded
- GGR 2011
- INMB 2015
- Country
- GGR Taiwan
- INMB United States
- Employees
- GGR N/A
- INMB N/A
- Industry
- GGR Auto Manufacturing
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- GGR Consumer Discretionary
- INMB Health Care
- Exchange
- GGR Nasdaq
- INMB Nasdaq
- Market Cap
- GGR 80.6M
- INMB 68.9M
- IPO Year
- GGR N/A
- INMB 2019
- Fundamental
- Price
- GGR $0.38
- INMB $2.31
- Analyst Decision
- GGR Hold
- INMB Buy
- Analyst Count
- GGR 2
- INMB 4
- Target Price
- GGR $0.50
- INMB $9.53
- AVG Volume (30 Days)
- GGR 477.4K
- INMB 6.9M
- Earning Date
- GGR 08-14-2025
- INMB 07-31-2025
- Dividend Yield
- GGR N/A
- INMB N/A
- EPS Growth
- GGR N/A
- INMB N/A
- EPS
- GGR N/A
- INMB N/A
- Revenue
- GGR $304,551,000.00
- INMB $50,000.00
- Revenue This Year
- GGR N/A
- INMB $82.14
- Revenue Next Year
- GGR $5.00
- INMB $28,750.98
- P/E Ratio
- GGR N/A
- INMB N/A
- Revenue Growth
- GGR N/A
- INMB N/A
- 52 Week Low
- GGR $0.19
- INMB $1.89
- 52 Week High
- GGR $1.65
- INMB $11.64
- Technical
- Relative Strength Index (RSI)
- GGR 80.44
- INMB 26.84
- Support Level
- GGR $0.24
- INMB $2.22
- Resistance Level
- GGR $0.42
- INMB $2.49
- Average True Range (ATR)
- GGR 0.02
- INMB 0.94
- MACD
- GGR 0.02
- INMB -0.24
- Stochastic Oscillator
- GGR 85.55
- INMB 4.31
About GGR Gogoro Inc.
Gogoro Inc is focused on eliminating the barriers to electric fuel adoption to bring swappable electric power within reach of every urban rider. Its battery swapping technology compromises an interoperable platform that seamlessly integrates a comprehensive ecosystem of hardware, software, and services, which consists of Gogoro Smart Batteries, GoStations, Gogoro Network Software & Battery Management Systems, Smartscooter, and related components and kits. Geographical presence in Taiwan and Other countries, majority of its revenue comes from Tiwan.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.